NexImmune, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2020 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
NexImmune, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2020 to Q2 2024.
  • NexImmune, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 1.38M shares, a 32.3% increase year-over-year.
  • NexImmune, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 1.05M shares, a 9.05% increase from 2022.
  • NexImmune, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 962K shares, a 95.2% decline from 2021.
  • NexImmune, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 20.2M shares, a 1509% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 1.38M +337K +32.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 1.25M +207K +19.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-20
Q4 2023 1.05M +87.1K +9.05% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-16
Q3 2023 1.05M +71.5K +7.32% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-17
Q2 2023 1.04M -21.8M -95.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 1.04M -21.8M -95.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-20
Q4 2022 962K -19.2M -95.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-16
Q3 2022 976K -21.7M -95.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-17
Q2 2022 22.9M +263K +1.16% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 22.8M +10.2M +80.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 20.2M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-28
Q3 2021 22.7M +21.4M +1705% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 22.6M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 12.6M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 1.25M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.